Exact Sciences and Genomic Health in a $2.8 billion deal

Exact Sciences is buying fellow cancer technologies firm Genomic Health in a $2.8 billion deal announced Monday.

If cleared by regulators, the combined company will employ roughly 1,000 people and is slated to have an R&D budget of about $200 million. The deal is expected to close by the end of 2019. 

Read more

Source: medtechdive

2 views0 comments

Recent Posts

See All

As seen by Harvard Health Publishing in 2020, these trends in cardiology play may play a vital role in the upcoming decades. 3 out of the 5 trends are in the field of medical devices. Additionally, 1